Myovant Sciences Ltd (MYOV)

BMG637AM1024 - Common Stock

26.98  -0.01 (-0.04%)

After market: 26.98 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
59.32M230.972M
289.37%		427.93M
85.27%
EBITDA
YoY % growth
-273.09M
-3.27%		-258.28M
5.42%		-185.968M
28.00%		-100.104M
46.17%		N/AN/AN/A
EBIT
YoY % growth
-274.89M
-3.80%		-260.78M
5.13%		-187.346M
28.16%		-100.907M
46.14%
Operating Margin
N/A-439.62%-81.11%-23.58%
EPS
YoY % growth
-3.32
18.63%		-2.83
14.76%		-2.21
21.91%		-1.78
19.42%		N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.52
17.83%
Revenue
Q2Q % growth		107.87M
87.38%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-32.985M
36.49%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 -0.59
13.24%		-0.48-0.11-21.78%
Q2 2023
Q2Q % growth		 -0.47
-104.35%		-0.500.035.48%
Q1 2023
Q2Q % growth		 -0.22
67.16%		-0.320.1032.17%
Q4 2022
Q2Q % growth		 -0.63
29.21%		-0.58-0.05-7.98%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 100.229M
84.11%		104.41M-4.181M-4.00%
Q2 2023
Q2Q % growth		 104.824M
34.56%		95.341M9.483M9.95%
Q1 2023
Q2Q % growth		 116.492M
183.69%		93.123M23.369M25.09%
Q4 2022
Q2Q % growth		 57.567M
133.92%		65.955M-8.388M-12.72%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 1.22% 1.22%
Revenue0% 0% 1.22% 1.22%